Fluor Corporation (FLR)

SpringWorks Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,820	8,459	6,674	4,925	3,503	2,247
Market Cap Growth	13.24%	26.76%	35.51%	40.60%	55.87%	-15.09%
Enterprise Value	5,396	6,659	5,657	3,754	2,731	2,033
Last Close Price	41.42	49.32	39.17	34.66	24.77	15.97
PE Ratio	1.67	3.94	80.41	46.46	-	-
Forward PE	16.64	16.56	14.80	20.17	21.99	18.10
PS Ratio	0.42	0.52	0.43	0.36	0.25	0.14
PB Ratio	1.92	2.12	3.25	2.47	2.24	1.78
P/TBV Ratio	1.90	2.26	3.85	3.12	3.06	2.73
P/FCF Ratio	28.07	12.74	66.08	-	-	30.78
P/OCF Ratio	19.49	10.22	31.48	158.86	140.11	12.08
PEG Ratio	-	1.28	1.28	1.28	-	-
EV/Sales Ratio	0.33	0.41	0.37	0.27	0.19	0.13
EV/EBITDA Ratio	14.24	14.57	16.94	16.25	8.43	5.88
EV/EBIT Ratio	17.75	17.34	21.76	23.76	10.93	8.44
EV/FCF Ratio	22.21	10.03	56.01	-	-	27.85
Debt / Equity Ratio	0.30	0.28	0.56	0.65	0.90	1.48
Debt / EBITDA Ratio	2.87	2.42	3.47	5.27	2.59	3.47
Debt / FCF Ratio	4.47	1.66	11.47	-	-	25.58
Asset Turnover	-	2.03	2.24	1.98	1.97	2.07
Quick Ratio	-	1.63	1.49	1.45	1.26	1.13
Current Ratio	-	1.69	1.60	1.57	1.43	1.41
Return on Equity (ROE)	-	68.96%	3.90%	4.10%	-25.86%	-21.14%
Return on Assets (ROA)	-	2.98%	2.35%	1.42%	2.17%	1.97%
Return on Capital (ROIC)	4.68%	5.78%	5.00%	3.15%	5.12%	4.50%
Return on Capital Employed (ROCE)	-	6.30%	6.80%	4.40%	7.20%	6.40%
Earnings Yield	60.64%	25.36%	2.08%	2.94%	-12.56%	-19.36%
FCF Yield	3.56%	7.85%	1.51%	-0.89%	-1.43%	3.25%
Dividend Yield	-	-	-	-	-	0.63%
Payout Ratio	-	-	20.86%	26.90%	-	-
Buyback Yield / Dilution	1.10%	-13.73%	-5.52%	-2.84%	-	-0.67%
Total Shareholder Return	1.10%	-13.73%	-5.52%	-2.84%	-	-0.04%

Updated Aug 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q